News Release
Notice of COVID-19 infection of our employees and suspension of telephone reception
Please be advised that two of our employees have tested positive with COVID-19. In order to contain its spread and impacts to our business, we have decided to limit the number of people who come to work in the office and thoroughly implement telework.
Therefore, we will not be able to answer phone calls at our switchboard number for a while. Instead, please contact us by email (infojapan@gnipharma.com) for any inquiriees. Depending on the contents, we will reply by e-mail for the time being. Also, please understand that it may take some time to reply.
We apologize for any inconvenience this may cause and thank you for your understanding.